Actively Recruiting
Evaluating Respiratory Multiplex PCR and Algorithm-Based Therapy to Improve Early Antibiotic Optimization in Ventilator-Associated Pneumonia A Randomized Controlled Trial
Led by Centre Hospitalier Universitaire de Nīmes · Updated on 2026-10-13
124
Participants Needed
2
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This research investigates the impact of combining respiratory multiplex PCR mPCR with algorithm-based therapy, designed using local epidemiology, on improving early optimization of initial antibiotic treatment in critically ill patients with ventilator-associated pneumonia VAP. The study compares this combined strategy to a conventional antibiotic treatment approach guided by clinician discretion and best practice recommendations. It is a bicentric, parallel-group, randomized controlled trial focused on early antibiotic optimization within 24 hours after respiratory sampling. Participants diagnosed with VAP undergo deep respiratory sample collection through mini bronchoalveolar lavage BAL, either via bronchoscopy or blind mini BAL. In the intervention group, samples are analyzed with both conventional methods and a broad-panel respiratory mPCR within 12 hours. Results from mPCR guide clinicians in adjusting antibiotic therapy early using a specific algorithm. The control group receives antibiotic therapy adjustments based on conventional sample analysis and clinical judgment without mPCR or algorithm support. During the study, researchers monitor the timing and effectiveness of antibiotic optimization, duration of broad-spectrum antibiotic exposure, clinical cure rates, mechanical ventilation use, ICU stay length, organ failure-free days, mortality, and infection rates. Laboratory tests include conventional cultures and susceptibility testing, with mPCR performance evaluated against these standards. The study also assesses hospital admission costs. Participation continues through treatment and outcome assessments up to 28 days, with safety and efficacy measures tracked throughout.
CONDITIONS
Brief Title
Combined Use of a Respiratory Multiplex PCR and Algorithm-based Therapy to Improve Early Optimization of Antibiotic Therapy in Critically Ill Patients With Ventilator-associated Pneumonia
Research Team
H
Hugo MARTINIERE, PH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here